GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Gross Margin %

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Gross Margin % : 75.92% (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Nobel Biocare Holding AG's Gross Profit for the six months ended in Dec. 2013 was $589.5 Mil. Nobel Biocare Holding AG's Revenue for the six months ended in Dec. 2013 was $776.4 Mil. Therefore, Nobel Biocare Holding AG's Gross Margin % for the quarter that ended in Dec. 2013 was 75.92%.


The historical rank and industry rank for Nobel Biocare Holding AG's Gross Margin % or its related term are showing as below:


NBHGF's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 52.9
* Ranked among companies with meaningful Gross Margin % only.

Nobel Biocare Holding AG had a gross margin of 75.92% for the quarter that ended in Dec. 2013 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Nobel Biocare Holding AG was 0.00% per year.


Nobel Biocare Holding AG Gross Margin % Historical Data

The historical data trend for Nobel Biocare Holding AG's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Gross Margin % Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.48 77.69 75.99 75.72 75.92

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.48 77.69 75.99 75.72 75.92

Competitive Comparison of Nobel Biocare Holding AG's Gross Margin %

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Gross Margin % falls into.



Nobel Biocare Holding AG Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Nobel Biocare Holding AG's Gross Margin for the fiscal year that ended in Dec. 2013 is calculated as

Gross Margin % (A: Dec. 2013 )=Gross Profit (A: Dec. 2013 ) / Revenue (A: Dec. 2013 )
=589.5 / 776.422
=(Revenue - Cost of Goods Sold) / Revenue
=(776.422 - 186.945) / 776.422
=75.92 %

Nobel Biocare Holding AG's Gross Margin for the quarter that ended in Dec. 2013 is calculated as


Gross Margin % (Q: Dec. 2013 )=Gross Profit (Q: Dec. 2013 ) / Revenue (Q: Dec. 2013 )
=589.5 / 776.422
=(Revenue - Cost of Goods Sold) / Revenue
=(776.422 - 186.945) / 776.422
=75.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Nobel Biocare Holding AG  (OTCPK:NBHGF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Nobel Biocare Holding AG had a gross margin of 75.92% for the quarter that ended in Dec. 2013 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Nobel Biocare Holding AG Gross Margin % Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines